NATIONAL DME COMPETITIVE BIDDING AMONG MEDICARE ANTI-FRAUD PROPOSALS FROM ADMINISTRATION; SENATE FINANCE MEMBERS SEEKING LOWER SURETY BOND THRESHOLD
This article was originally published in The Gray Sheet
The White House is proposing to expand Medicare competitive bidding programs for durable medical equipment beyond their current demonstration status and implement them nationally. Under one of 10 Medicare waste, fraud and abuse legislative initiatives unveiled by President Clinton Jan. 24 during his weekly radio address, the Health Care Financing Administration would "do what most private and other government health care purchasers do to control cost -- lower costs by injecting competition into the pricing for equipment and non-physician services."
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.